drugset / Trial / NCT04456712

Effect of Ciprofloxacin Versus Levofloxacin on QTc-interval and Dysglycemia

NCT04456712

Phase 4 Completed 200 enrolled Beni-Suef University
RandomizedParallel-groupQuadruple-blindOther

Summary

To compare intravenous levofloxacin and ciprofloxacin regarding their risk on the corrected QT interval (QTc) prolongation and dysglycemia in diabetic and non-diabetic patients.

Timeline

Start
2018-06-01
Primary completion
2018-11-30
Completion
2018-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ciprofloxacin Small molecule 400 mg Intravenous
Subject Levofloxacin Small molecule 750 mg Intravenous

Indications

No indication recorded.